| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8722747 | HPB | 2018 | 7 Pages |
Abstract
The liver-first strategy is currently the dominant strategy for sCRLM in patients with rectal cancer in Sweden. No difference in overall survival was noted between strategies.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Valentinus T. Valdimarsson, Ingvar Syk, Gert Lindell, Agneta Norén, Bengt Isaksson, Per Sandström, Magnus Rizell, Bjarne Ardnor, Christian Sturesson,